Clinical trials with MRNA electroporated dendritic cells for stage III/IV melanoma patients

類似資料

• Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma
  著者:: Thielemans, Kris, 等
  出版事項: (2014)
• Characterization of CD8(+) T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL)
  著者:: Benteyn, Daphné, 等
  出版事項: (2013)
• TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
  著者:: De Keersmaecker, Brenda, 等
  出版事項: (2020)
• TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
  著者:: Bart Neyns, 等
  出版事項: (2020-05-01)
• Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4(+) and CD8(+) T Cells in Melanoma Patients
  著者:: Van Nuffel, An MT, 等
  出版事項: (2012)